Fuller & Thaler Asset Management Inc. trimmed its stake in Express Scripts Holding Company (NASDAQ:ESRX) by 9.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,500 shares of the company’s stock after selling 1,000 shares during the period. Fuller & Thaler Asset Management Inc.’s holdings in Express Scripts were worth $602,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Renaissance Group LLC increased its holdings in Express Scripts by 10.0% in the third quarter. Renaissance Group LLC now owns 440,652 shares of the company’s stock valued at $27,902,000 after purchasing an additional 40,068 shares during the period. Pacer Advisors Inc. increased its holdings in Express Scripts by 6.9% in the third quarter. Pacer Advisors Inc. now owns 30,368 shares of the company’s stock valued at $1,923,000 after purchasing an additional 1,958 shares during the period. Exencial Wealth Advisors LLC acquired a new stake in Express Scripts during the 3rd quarter worth about $1,203,000. Thompson Siegel & Walmsley LLC grew its holdings in Express Scripts by 38.9% during the 3rd quarter. Thompson Siegel & Walmsley LLC now owns 126,592 shares of the company’s stock worth $8,016,000 after acquiring an additional 35,429 shares during the period. Finally, Rational Advisors LLC acquired a new stake in Express Scripts during the 3rd quarter worth about $260,000. Institutional investors and hedge funds own 89.34% of the company’s stock.

In other news, VP Phyllis S. Anderson sold 578 shares of the stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $63.13, for a total transaction of $36,489.14. Following the transaction, the vice president now owns 10,530 shares of the company’s stock, valued at approximately $664,758.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the transaction, the director now directly owns 11,500 shares in the company, valued at approximately $735,195. The disclosure for this sale can be found here. Insiders have sold a total of 5,121 shares of company stock worth $325,920 in the last three months. Insiders own 0.68% of the company’s stock.

A number of analysts have weighed in on the company. ValuEngine upgraded Express Scripts from a “hold” rating to a “buy” rating in a report on Monday, October 2nd. Robert W. Baird reiterated a “hold” rating and set a $56.00 price target on shares of Express Scripts in a report on Friday, September 1st. BidaskClub downgraded Express Scripts from a “sell” rating to a “strong sell” rating in a report on Friday, August 4th. Raymond James Financial, Inc. reiterated an “underperform” rating on shares of Express Scripts in a report on Monday, October 9th. Finally, UBS AG downgraded Express Scripts from a “market perform” rating to an “underperform” rating in a report on Monday, October 9th. Seven research analysts have rated the stock with a sell rating, ten have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. Express Scripts has an average rating of “Hold” and a consensus target price of $69.53.

Express Scripts Holding Company (ESRX) opened at $61.18 on Friday. The stock has a market cap of $34,650.70, a PE ratio of 8.94, a PEG ratio of 0.90 and a beta of 0.88. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding Company has a 1 year low of $55.80 and a 1 year high of $77.50.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, October 24th. The company reported $1.90 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $1.90. The company had revenue of $24.68 billion for the quarter, compared to analysts’ expectations of $25.68 billion. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business’s revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.74 EPS. research analysts forecast that Express Scripts Holding Company will post 7.01 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was first reported by Watch List News and is owned by of Watch List News. If you are reading this report on another site, it was copied illegally and reposted in violation of United States & international trademark & copyright laws. The correct version of this report can be viewed at https://www.watchlistnews.com/fuller-thaler-asset-management-inc-sells-1000-shares-of-express-scripts-holding-company-esrx/1726834.html.

Express Scripts Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with Analyst Ratings Network's FREE daily email newsletter.